Enanta Pharmaceuticals Inc
F:9EP
Enanta Pharmaceuticals Inc
F:9EP
Price:
11.3
EUR
-2.59%
Market Closed
Market Cap:
€239.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
E
|
Enanta Pharmaceuticals Inc
F:9EP
|
US |
|
Bragg Gaming Group Inc
F:SL4
|
CA |
|
P
|
Prestige Cars International Inc
OTC:PREC
|
US |
|
I
|
Innotech Corp
OTC:INTH
|
US |
|
B
|
Buxton Resources Ltd
F:3B4
|
AU |
Wall St Price Targets
9EP Price Targets Summary
Enanta Pharmaceuticals Inc
Enanta Pharmaceuticals Inc
Wall Street analysts forecast 9EP stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 9EP is 16.64 EUR with a low forecast of 14.43 EUR and a high forecast of 24 EUR.
Lowest Forecast
Price Target
14.43
EUR
28% Upside
Average Forecast
Price Target
16.64
EUR
47% Upside
Highest Forecast
Price Target
24
EUR
112% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 9EP's stock price target?
Price Target
16.64
EUR
16.64
EUR
According to Wall Street analysts, the average 1-year price target for 9EP is 16.64 EUR with a low forecast of 14.43 EUR and a high forecast of 24 EUR.
What is the Revenue forecast for Enanta Pharmaceuticals Inc?
Projected CAGR
24%
24%
Over the last 13 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 8 years is 24%.
